# TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

> **NCT01711658** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 142 (actual)

## Conditions studied

- Non-HPV Locally Advanced Head and Neck Cancer

## Interventions

- **RADIATION:** IMRT
- **DRUG:** Cisplatin
- **DRUG:** placebo
- **DRUG:** Lapatinib

## Key facts

- **NCT ID:** NCT01711658
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-15
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-09-21
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711658, "TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01711658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*